Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05884216
Other study ID # CRD-04-1642-01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 30, 2023
Est. completion date December 2024

Study information

Verified date February 2024
Source Gravitas Medical, Inc.
Contact Carleen Tabari
Phone 6505166508
Email ctabari@gravitasmedinc.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the safety and effectiveness of the Entarik Feeding Tube System in an adult ICU patient population for the administration of nutrition, fluids and medications.


Recruitment information / eligibility

Status Recruiting
Enrollment 110
Est. completion date December 2024
Est. primary completion date September 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Must be able to swallow tabletsAt least 18 years old - Able to provide informed consent or ability to have a legally authorized representative provide informed consent - Adults in the ICU requiring an 8Fr, 10Fr, or 12Fr NG tube. The size of the feeding tube should be determined clinically, and the Entarik Feeding Tube should only be placed if that size is appropriate. - Suitable to start enteral (gastric but no post-pyloric) feeding - Anticipated to receive enteral feeding (either bolus or continuous feeds) for more than 6 hours and conclude the enteral nutrition while in the care of the ICU. If enteral nutrition has already been initiated, indicated for replacement of an NG feeding tube Note: Both subjects on a ventilator (non-invasive or invasive ventilation) or not requiring a ventilator are eligible for this study. Exclusion Criteria: - inability to receive a feeding tube including subjects with known history of issues such as esophagitis or strictures, frequent nose bleeds, basilar skull fracture or GI bleeding disorders - Known major upper airway malformation - Known major GI abnormality, upper GI malignancy, or partial gastric resection - History of gastroparesis - Currently pregnant - NPO status - expected to remain NPO for the following 72 hours. - Patient needs an MRI in the immediate future (e.g., 6-12h) where placement of the feeding tube (non-MRI compatible) is going to mandate replacement with standard feeding tube - Critically ill, facing imminent death - Deemed unsuitable for enrollment in study by the investigator based on subject's history (e.g., active anticoagulation therapy) or physical examination

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Entarik Feeding Tube System
Entarik Feeding Tube: The Entarik Feeding Tube is intended for the administration of nutrition, fluids and medications by the nasoenteric route for patients who have an intact gastrointestinal tract but are physically unable to manage nutritional intake through normal mastication and deglutition. Entarik Feeding Tube System: The Entarik Feeding Tube System is designed to aid qualified operators in the placement of the Entarik Feeding Tube (Entarik FT) into the stomach of patients requiring enteral feeding. The Entarik FT is equipped with sensors designed to provide information about the location of the tube tip relative to the stomach, thus assisting in reducing the incidence of misplacement during first positioning. The Entarik Monitor also monitors the feeding tube position continuously during the course of feeding and automatically and in real-time alerts of tube migration.
Entarik Feeding Tube System without monitoring
Entarik Feeding Tube: The Entarik Feeding Tube is intended for the administration of nutrition, fluids and medications by the nasoenteric route for patients who have an intact gastrointestinal tract but are physically unable to manage nutritional intake through normal mastication and deglutition. Entarik Feeding Tube System: The Entarik Feeding Tube System will collect data from the Entarik Feeding Tube. There will be no monitoring or dislodgement alerts, and no placement guidance.

Locations

Country Name City State
United States Nova Clinical Research at HCA Florida Blake Hospital Bradenton Florida
United States HCA Chippenham and Johnston-Willis Medical Center Richmond Virginia

Sponsors (1)

Lead Sponsor Collaborator
Gravitas Medical, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of accurate verifications of anatomical locations of the tip of the Entarik feeding tube. The position of the feeding tube tip as processed by the Entarik placement algorithm will be compared to x-ray. All patients will receive placement verification per institutional standard of care. 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05914064 - Gravitas Feeding Tube System Placement Validation in Neonates N/A
Completed NCT03697642 - Nasopharyngeal Airway Guide Nasogastric Tube Placement N/A
Completed NCT05517707 - Gravitas Feeding Tube System Placement in Neonates
Completed NCT05040191 - The Effect of Haptic Interactive Virtual Reality on Nasogastric Tube Practice Teaching N/A
Withdrawn NCT04104295 - The Use of Ultrasound in Nasogastric Tube Placement in Children Admitted to the Pediatric ICU N/A
Not yet recruiting NCT05817864 - Diagnostic Accuracy of Capnography in Nasogastric Tube Placement
Completed NCT04682925 - Effect of Evidence-Based Skin Care and Hydrocolloid Dressing in the Prevention of Nasogastric-Related Pressure Injury N/A
Recruiting NCT06262815 - The Utility of Treatment With Nasogastric Tube Placement for Small Bowel Obstruction